Common use of Miscellenous Clause in Contracts

Miscellenous. 16.1 The schedules form part of this Agreement and shall have same effect as provisions of this Agreement. 16.2 Any amendment to this Agreement may be made only by a written instrument signed by parties hereto. The amended or supplemented provisions shall form part of this Agreement. 16.3 This Agreement shall inure for the benefit of and be binding upon parties hereto and their respective successors and assigns. 16.4 In case any provision of this Agreement is determined to be invalid by the arbitral tribunal, the validity of the remained provisions shall not in any way be affected or impaired thereby. 16.5 This Agreement constitutes the entire agreement concerning the transfer of shares in YANTAI MEDGENN and relevant issues, and shall supersede any and all previous draft agreements, intention, agreements, promises, statements and arrangements, whether written or oral, between parties hereto. 16.6 All notices hereunder shall be in writing and in Chinese, and shall be sent by registered post or facsimile transmission or other electronic communication. Notices shall be deemed to have been duly given only if sent to parties hereto at their respective registered office. If such notices are delivered by registered post, such notices shall be deemed given on the date indicated in the return receipt. If such notices are delivered by facsimile transmission, such notices shall be deemed given on the date indicated in the transmittal confirmation. 16.7 This Agreement shall be executed in seven (7) counterparts, and each party hereto shall keep one (1) counterpart and the Witness shall keep one (1) counterpart. The rest three (3) counterparts shall be used to file relevant applications to competent examining and approving authorities.

Appears in 1 contract

Sources: Share Transfer Agreement (Simcere Pharmaceutical Group)

Miscellenous. 16.1 The schedules form part of this Agreement and shall have same effect as provisions of this Agreement. 16.2 Any amendment to this Agreement may be made only by a written instrument signed by parties hereto. The amended or supplemented provisions shall form part of this Agreement. 16.3 This Agreement shall inure for the benefit of and be binding upon parties hereto and their respective successors and assigns. 16.4 In case any provision of this Agreement is determined to be invalid by the arbitral tribunal, the validity of the remained provisions shall not in any way be affected or impaired thereby. 16.5 This Agreement constitutes the entire agreement concerning the transfer of shares in YANTAI MEDGENN and relevant issues, and shall supersede any and all previous draft agreements, intention, agreements, promises, statements and arrangements, whether written or oral, between parties hereto. 16.6 All notices hereunder shall be in writing and in Chinese, and shall be sent by registered post or facsimile transmission or other electronic communication. Notices shall be deemed to have been duly given only if sent to parties hereto at their respective registered office. If such notices are delivered by registered post, such notices shall be deemed given on the date indicated in the return receipt. If such notices are delivered by facsimile transmission, such notices shall be deemed given on the date indicated in the transmittal confirmation. 16.7 This Agreement shall be executed in seven eight (7) 8) counterparts, and each party hereto shall keep one (1) counterpart and the Witness shall keep one (1) counterpart. The rest three (3) counterparts shall be used to file relevant applications to competent examining and approving authorities.

Appears in 1 contract

Sources: Share Transfer Agreement (Simcere Pharmaceutical Group)